Agency / Source: SCOR SE

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

SCOR Partners with Bowtie and Take2 on Innovative Cancer Screening Solution - 85% of nasopharyngeal cancer patients are from Asia. Early detection increases survival rate by nearly 30% - / /
SCOR Partners with Bowtie and Take2 on Innovative Cancer Screening Solution


PRZOOM - /newswire/ - Paris, Ile-de-France, France, 2022/11/02 - 85% of nasopharyngeal cancer patients are from Asia. Early detection increases survival rate by nearly 30% - / /

Your Banner Ad Here instead - Showing along with ALL Articles covering Insurance / Risk Management Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


SCOR has partnered with Bowtie, Hong Kong’s first virtual insurer, and Take2, a healthcare and biotech company, to develop an innovative cancer screening solution. Bowtie will fully sponsor 1,300 of its selected life insurance customers within the age group of 40 - 60 to conduct a Take2 Prophecy™ Test for Nasopharyngeal Cancer (NPC).

Nearly 85% of the world's NPC patients come from Asia, and the incidence rate of NPC among Hong Kongers is as high as 5 to 6 times the global average(1). In Hong Kong, NPC is one of the five most common cancers among men aged 45 to 64(2), the age group with the highest median employment income(3). Family finances are likely to be severely stressed if members of this age group fall ill.

Statistics from the Hong Kong Hospital Authority highlight that 70 - 80% of the city’s NPC patients were diagnosed at stages 3 & 4 (which are classified as late stages)(4), showing that effective NPC screening solutions are lacking. In comparison, according to a clinical study conducted by a top local university, utilising Next-generation Sequencing and state-of-the-art technologies for the early detection of NPC could enable patients to be diagnosed at earlier stages (stages 1 & 2), which was the case for 70% of the NPC patients identified in the study. If an individual is diagnosed with NPC at an early stage, the survival rate in the next 5 years can reach 90%, which is almost 30% higher than a diagnosis at later stages(5).

SCOR, Bowtie and Take2 aim to help the public learn about the potential risks of NPC, in order to conduct early NPC detection. Selected Bowtie insureds can enjoy a Take2 Prophecy™ NPC detection Test at Bowtie’s medical clinic, Bowtie & JP Health, for the service fee only(6). The test result will not affect their current coverage, underwriting results or claim eligibility with Bowtie. For positive test results, a free follow-up medical consultation will be provided by Bowtie & JP Health.

The application process is simple. Users can:

• Access the "Health Services” page after logging into their Bowtie account;
• Obtain the QR code for a Take2 Prophecy™ NPC detection, and save the screenshot on their mobile;
• Make an appointment on the Bowtie & JP Health website, or call 3169 2269
• Present the QR code on their visit to Bowtie & JP Health and conduct the test.

"It has come to our concern that the risk of NPC in men between the ages of 40 and 60 is extremely high. Imagine if these people who are at the peak of their careers, who are also the breadwinner of their families, are diagnosed with serious illnesses, not only are they leaving their family worried, their family expenses might also become unaffordable. Our partnership enables more people to realise the importance of physical examinations as a way to prevent diseases,” says Dr. Jacky Lio, Chief Medical Officer, Bowtie.

"Take2 has entered into a definitive licence agreement with GRAIL for the exclusive worldwide rights to an intellectual property portfolio for the early detection of NPC. Adopting the Next-generation Sequencing (NGS) technology in NPC screening, it allows clients to receive highly accurate tests in a convenient and efficient manner. We are grateful to Take2 and SCOR for supporting this project," Dr. Lio adds.

"One mission of Take2 is to provide individuals a second chance in health through the early detection of disease. NPC is most prevalent in China and the ASEAN countries, and is a deadly cancer as the majority of cases are diagnosed at late stages. As the pioneer who brings disruptive innovation to the healthcare industry, Take2 aims at marking the advent of a new era across Asia," says Professor Dennis Lo, Founder of Take2.

"We are delighted to collaborate with Bowtie and SCOR to promote cancer awareness and the importance of early detection of NPC. Leveraging the fast-growing customer base of Bowtie, we will make our early detection technology for NPC widely accessible to those who need it most," Carmen Lee, Vice President of Take2, adds.

“As one of the largest reinsurers in the world, SCOR has a responsibility to society to help transform traditional insurance into a health-improving journey which produces better outcomes for our clients and policyholders. With this partnership, we help to bridge the gap between medical advancements and their impact on life insurance by bringing innovative solutions to our clients. SCOR is incredibly proud to embark on this journey with Bowtie and Take2,” says Tony Ho, Head of South Asia, SCOR Life & Health.

About Bowtie

The Bowtie Life Insurance Company Limited ( is an authorised life insurance company and Hong Kong’s very first virtual insurer approved under the Fast Track pilot scheme. Through the use of modern technology and medical expertise, Bowtie offers an agent-free, commission-free and more convenient online platform for customers to quote, apply and claim for health insurance plans certified by the Health Bureau under the Voluntary Health Insurance Scheme (VHIS) anytime anywhere. Bowtie is backed by Mitsui & Co., Ltd, Sun Life Financial and supported by leading international reinsurers.

About Take2

Take2 ( is a healthcare start-up which explores, invents, and builds empowering platforms to harness the power of biomedical sciences and informatics to deliver better healthcare solutions to individuals and communities with actionable information and results. Headquartered in Hong Kong, China, Take2 aims to be a key driver that makes the most disruptive healthcare inventions widely accessible to the public in China and Asia.

About SCOR

SCOR (, a leading global reinsurer, offers its clients a diversified and innovative range of reinsurance and insurance solutions and services to control and manage risk. Applying “The Art & Science of Risk”, SCOR uses its industry-recognized expertise and cutting-edge financial solutions to serve its clients and contribute to the welfare and resilience of society.

SCOR offers its clients an optimal level of security with its AA- rating or equivalent from S&P, Moody’s, Fitch and AM Best.

The Group generated premiums of more than EUR 17.5 billion in 2021 and serves clients in more than 160 countries from its 36 offices worldwide.

(1) Health Tips from Take2 Health
(2) Hospital Authority
(3) "Quarterly Report on General Household Survey" for the second quarter of 2022 published by the Census and Statistics Department
(4) Chan, K. C. Allen, et al. “Analysis of Plasma Epstein Barr Virus DNA to Screen for Nasopharyngeal Cancer.” New England Journal of Medicine, vol. 377, no. 6, 2017, pp. 513 22
(5) Take2 Health
(6) This offer is subject to terms and conditions, testing is free; Bowtie & JP Health will charge for clinic services

Your Banner Ad Here instead - Showing along with ALL Articles covering Insurance / Risk Management Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Agency / Source: SCOR SE


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker


Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #
  Your Banner Ad showing on ALL
Insurance / Risk Management articles,
CATCH Visitors via Your Competitors Announcements!

SCOR Partners with Bowtie and Take2 on Innovative Cancer Screening Solution

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Cancer Screening | SCOR
Contact: Press Office - 
+33(0)1 58 44 70 00 press[.]
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any SCOR SE securities in any jurisdiction including any other companies listed or named in this release.

Insurance / Risk Management via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Press Releases From SCOR SE / Company Profile

Read Insurance / Risk Management Most Recent Related Press Releases:

SCOR Partners with DGTAL to Push AI-powered Claims Assessments
Targa Telematics Applauded by Frost & Sullivan for Ensuring Cost Savings, Improving Driver Safety with its Intelligent Mobility Solutions
OCTO Telematics Applauded by Frost & Sullivan for its Versatile Telematic Solutions and Demonstrated Leadership via Continuous Innovation
Frost & Sullivan and TERI to Recognize Indian Organizations Embedding Sustainability with Economic Value Creation At its Sustainability 4.0 Awards
Zelros Receives the 2021 European Technology Innovation Leadership Award from Frost & Sullivan
Verisk Analytics Lauded by Frost & Sullivan for Pioneering Telematics Data Exchange for Usage-Based Insurance in North America
FIS Named Category Leader in Chartis Report for Sell-Side Risk Management Technology
ALM Launches FC&S Expert Coverage Interpretation
Auto Insurers Seize Growth Opportunities by Offering Financial and Insurance Tools Over Digital Platforms
Insurance and Benefits Thought Leaders Set to Gather At 15th Annual BenefitsPRO Broker Expo

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  RightITnow, Inc.



  ©2005-2024 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today